- Avis de convocation à l’assemblée générale 2024 des actionnaires ONWARD® et propositions de résolutions
- ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions
- ONWARD® Medical annonce ses résultats financiers et opérationnels pour l’exercice 2023 et partage les faits qui ont marqué l’exercice 2024 à ce jour
- ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date
- ONWARD® Medical Announces Publication of Full Year 2023 Financial Results and Business Update Webcast
- Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00
- ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System
- ONWARD® Medical Publishes Closing of Accelerated Bookbuild Offering and Public Offering in France
- ONWARD® Medical Publishes Prospectus for Listing of New Shares
- ONWARD® Medical Successfully Raises €20 Million in a Capital Increase by Way of an Accelerated Bookbuild Offering and by Way of a Public Offering in France
More ▼
Key statistics
As of last trade ONWARD Medical NV (ONWD:BRU) traded at 4.85, -26.29% below its 52-week high of 6.58, set on Feb 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.84 |
---|---|
High | 4.88 |
Low | 4.76 |
Bid | 4.85 |
Offer | 4.88 |
Previous close | 4.75 |
Average volume | 56.19k |
---|---|
Shares outstanding | 34.63m |
Free float | 28.07m |
P/E (TTM) | -- |
Market cap | 164.49m EUR |
EPS (TTM) | -1.20 EUR |
Data delayed at least 15 minutes, as of May 03 2024 16:01 BST.
More ▼